K
Kazumori Kawakami
Researcher at Kagoshima University
Publications - 47
Citations - 3664
Kazumori Kawakami is an academic researcher from Kagoshima University. The author has contributed to research in topics: microRNA & Cell growth. The author has an hindex of 33, co-authored 47 publications receiving 3485 citations. Previous affiliations of Kazumori Kawakami include University of California, San Francisco & Veterans Health Administration.
Papers
More filters
Journal ArticleDOI
Identification of novel microRNA targets based on microRNA signatures in bladder cancer.
Takahiro Ichimi,Hideki Enokida,Yasushi Okuno,Ryo Kunimoto,Takeshi Chiyomaru,Ken Kawamoto,Kazuya Kawahara,Kazuki Toki,Kazumori Kawakami,Kenryu Nishiyama,Gozoh Tsujimoto,Masayuki Nakagawa,Naohiko Seki +12 more
TL;DR: The target search algorithm and gene‐expression profiling in BCs revealed that Keratin7 (KRT7) mRNA was a common target of the downregulated miRNAs, and the mRNA expression levels of KRT7 were significantly higher inBCs than in NBEs.
Journal ArticleDOI
The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer
Hirofumi Yoshino,Takeshi Chiyomaru,Hideki Enokida,Kazumori Kawakami,S. Tatarano,Kenryu Nishiyama,Nijiro Nohata,Naohiko Seki,Masayuki Nakagawa +8 more
TL;DR: The downregulation ofmiR-1 and miR-133a was a frequent event in BC, and these miRNAs were recognised as tumour suppressive and TAGLN2 may be a target of both mi RNAs and had a potential oncogenic function.
Journal ArticleDOI
BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer
Shahana Majid,Altaf A. Dar,Ardalan E. Ahmad,Hiroshi Hirata,Kazumori Kawakami,Varahram Shahryari,Sharanjot Saini,Yuichiro Tanaka,Angela V. Dahiya,Gaurav Khatri,Rajvir Dahiya +10 more
TL;DR: This is the first report to show that BTG3 is epigenetically silenced in RCC and can be reactivated by genistein-induced promoter demethylation and active histone modification, making it a promising candidate for epigenetic therapy in renal carcinoma.
Journal ArticleDOI
MiR-96 and miR-183 detection in urine serve as potential tumor markers of urothelial carcinoma: correlation with stage and grade, and comparison with urinary cytology
Yasutoshi Yamada,Hideki Enokida,Satoko Kojima,Kazumori Kawakami,Takeshi Chiyomaru,Shuichi Tatarano,Hirofumi Yoshino,Kazuya Kawahara,Kenryu Nishiyama,Naohiko Seki,Masayuki Nakagawa +10 more
TL;DR: MiR‐96 and miR‐183 in urine are promising tumor markers for UC and may be a good diagnostic marker in combination with urinary cytology.
Journal ArticleDOI
Tumour suppressors miR-1 and miR-133a target the oncogenic function of purine nucleoside phosphorylase ( PNP ) in prostate cancer
Satoko Kojima,Takeshi Chiyomaru,Kazumori Kawakami,Hirofumi Yoshino,Hideki Enokida,Nijiro Nohata,Miki Fuse,Tomohiko Ichikawa,Yukio Naya,Masayuki Nakagawa,Naohiko Seki +10 more
TL;DR: The PNP is a novel target gene of both miRNAs and potentially functions as an oncogene and may provide new insights into the underlying causes of PCa oncogenesis, which is a frequent event in PCa and both function as tumour suppressors.